INSM
INSM clinical trials: INSMED Inc
Every trial on ClinicalTrials.gov where INSMED Inc is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 54
- Trials linked
- 50
- As lead sponsor
- 4
- As collaborator
- 3
- Primary completions as lead sponsor, next 90 days
INSM on the catalyst calendar · INSM registry changes
- Primary completion Jan 22, 2031Sponsor estimatePhase 3NCT07234032An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated...Insmed Incorporated · Pulmonary HypertensionRecruitingINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 22, 2027Sponsor estimatePhase 1NCT07765706A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy ParticipantsInsmed Incorporated · Healthy VolunteersRecruitingINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 7, 2027Sponsor estimatePhase 1NCT07643155A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in...Insmed Incorporated · Hepatic ImpairmentRecruitingINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2025ActualPhase 2NCT06013241A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)Insmed Incorporated · Chronic Rhinosinusitis Without Nasal PolypsCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2030Sponsor estimatePhase 3NCT07805785A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary...Insmed Incorporated · Progressive Pulmonary FibrosisRecruitingINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 30, 2028Sponsor estimatePhase 3NCT07179380Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With...Insmed Incorporated · Pulmonary HypertensionRecruitingINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT06939647An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension...Insmed Incorporated · Pulmonary Arterial HypertensionAvailableINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2026Sponsor estimatePhase 2/Phase 3NCT05649748An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)Insmed Incorporated · Pulmonary Arterial HypertensionActive, not recruitingINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 28, 2028Sponsor estimatePhase 3NCT07481981A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary...Insmed Incorporated · Pulmonary Arterial HypertensionRecruitingINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 25, 2026Sponsor estimatePhase 1NCT07859007A Study to Assess the Potential CYP3A Induction Effect of Brensocatib on the Pharmacokinetics (PK) of Midazolam in Healthy ParticipantsInsmed Incorporated · Healthy VolunteersNot yet recruitingINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 3, 2024ActualPhase 2NCT06101823Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)Insmed Incorporated · Atopic DermatitisCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 12, 2026ActualPhase 2NCT06685835A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)Insmed Incorporated · Hidradenitis SuppurativaTerminatedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2026ActualPhase 2/Phase 3NCT05649722An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung...Insmed Incorporated · Pulmonary HypertensionCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 27, 2025ActualPhase 2NCT05147805A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary...Insmed Incorporated · Pulmonary Arterial HypertensionCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 1, 2022ActualPhase 2NCT05090904A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic FibrosisInsmed Incorporated · Cystic FibrosisCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 21, 2025ActualPhase 3NCT04677569Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused...Insmed Incorporated · Mycobacterium Infections, NontuberculousCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 28, 2024ActualPhase 3NCT04594369A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis BronchiectasisInsmed Incorporated · Non-Cystic Fibrosis BronchiectasisCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 25, 2025ActualPhase 1NCT07102316A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder...Insmed Incorporated · Healthy VolunteersCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT05344508An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis BronchiectasisInsmed Incorporated · Non-Cystic Fibrosis BronchiectasisApproved for marketingINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 14, 2024ActualPhase 2NCT05176951A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension...Insmed Incorporated · Pulmonary HypertensionCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 9, 2023ActualPhase 3NCT04677543Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium...Insmed Incorporated · Mycobacterium Infections, NontuberculousCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 24, 2024ActualPhase 1NCT06344728A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy ParticipantsInsmed Incorporated · Healthy ParticipantsCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 8, 2005ActualPhase 1NCT06238856Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF)...Insmed Incorporated · Cystic FibrosisCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 4, 2024ActualPhase 1NCT06178783A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy ParticipantsInsmed Incorporated · Healthy VolunteersCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 18, 2015ActualPhase 1NCT06193031A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy ParticipantsInsmed Incorporated · Healthy VolunteersCompletedINSMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 29 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner